sec filing
CV
NASDAQ · CVKD
Cadrenal Therapeutics, Inc. Common Stock
Healthcare · Biotechnology
$0.91
Down-$0.02 (-2.10%)
Updated Oct 11, 2026, 2:03 AM
SID Score
3.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 22.83M
- P/E ratio
- -1.56
- Dividend yield
- 0.00%
- 52-week range
- $0.85 – $8.35
- Volume
- 83.75K
- Avg. volume
- 27.14K
Price performance · CVKD
CVKD price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
CVKD closed at $0.91 after 20 trading sessions, down 14.14% for the selected period.
- Last close
- $0.91
- Period change
- -14.14%
- Period low
- $0.91
- Period high
- $1.32
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $0.974 | $0.974 | $0.9004 | $0.9101 | 83.75K |
| Oct 8, 2026 | $0.9939 | $0.9939 | $0.8701 | $0.9296 | 311.2K |
| Oct 7, 2026 | $1.01 | $1.07 | $0.9169 | $0.9723 | 1.79M |
| Oct 6, 2026 | $0.9433 | $1.05 | $0.9004 | $0.99 | 98.65K |
| Oct 5, 2026 | $0.97 | $0.9999 | $0.935 | $0.9458 | 63.36K |
| Oct 2, 2026 | $0.98 | $1.005 | $0.85 | $0.9402 | 149.95K |
| Oct 1, 2026 | $1.09 | $1.09 | $0.97 | $0.97 | 111.33K |
| Sep 30, 2026 | $1.10 | $1.10 | $1.05 | $1.08 | 21.8K |
| Sep 29, 2026 | $1.10 | $1.13 | $1.08 | $1.09 | 38.76K |
| Sep 28, 2026 | $1.16 | $1.16 | $1.07 | $1.12 | 75.65K |
| Sep 25, 2026 | $1.25 | $1.25 | $1.13 | $1.15 | 224.86K |
| Sep 24, 2026 | $1.31 | $1.355 | $1.19 | $1.20 | 119.23K |
| Sep 23, 2026 | $1.12 | $1.3475 | $1.06 | $1.32 | 271.11K |
| Sep 22, 2026 | $1.11 | $1.1386 | $1.06 | $1.12 | 74.03K |
| Sep 21, 2026 | $1.07 | $1.11 | $1.06 | $1.09 | 66.89K |
| Sep 18, 2026 | $1.12 | $1.16 | $1.07 | $1.07 | 113.7K |
| Sep 17, 2026 | $1.10 | $1.14 | $1.08 | $1.12 | 44.9K |
| Sep 16, 2026 | $1.05 | $1.10 | $1.01 | $1.08 | 56.33K |
| Sep 15, 2026 | $1.06 | $1.1199 | $1.04 | $1.05 | 56.4K |
| Sep 14, 2026 | $1.07 | $1.10 | $1.0542 | $1.06 | 49.75K |
Latest CVKD news
The latest Smart Investors Daily articles mentioning CVKD.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…